Study Finds Nurse Educators Significantly Increase Awareness For Product Launch

Main Category: Pharma Industry / Biotech Industry
Also Included In: Nursing / Midwifery;  Conferences
Article Date: 05 Feb 2010 - 1:00 PDT

email to a friend   printer friendly   opinions  

Quintiles have announced findings from a recent study from a program in which a team of 19 nurse educators helped raise awareness of a newly approved oncology drug for a major pharmaceutical company from 37% to 57%. The results are from an awareness study of 150 clinical practice registered nurses who were provided a survey to evaluate their knowledge of the new chemotherapy agent within weeks of what was a successful oncology product launch.

For the United States launch, the pharma company had to recruit, train and deploy - within five weeks - a team of highly qualified oncology nurse educators to inform clinical practice registered nurses about a new therapy. To reach this ambitious goal, Quintiles was chosen as an ally, based on oncology expertise and a track record of rapidly recruiting high quality teams to deliver desired outcomes.

Along with significantly enhancing awareness, Quintiles achieved 125% of goal for institutions visited per day, reached 137% of goal for daily practitioner interactions, and contacted more than 5,000 accounts.

"These results are evidence of our desire to educate and motivate patients and clinicians for optimal health management outcomes," said Stewart Rosen M.D., Vice President, Medical Affairs and Health Management Solutions. "In today's New Health landscape, where the rules are changing on all fronts, customers increasingly need an ally to navigate risk and achieve desired outcomes. Because of our breadth and agility, Qunitiles is uniquely qualified to deliver on promises to our customers and ultimately to patients."

In the United States alone, Quintiles has deployed more than 53 teams with 1,000 clinical/nurse educators across a wide range of therapeutic areas.

Quintiles will be joined by a host of other industry leaders and senior-level executives speaking at the eyeforpharma Oncology USA 2010 Summit in Boston, March 23-24. To learn more about the conference, please click here.

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of 23,000 engaged professionals in more than 50 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit http://www.quintiles.com.

Source:
Claire Poole
Vice President
eyeforpharma

T: +44 (0) 207 375 7516
F: +44 (0) 207 375 7576
E: cpoole@eyeforpharma.com
US Toll Free: + 1 800 814 3459 x 7516

• Additional
• References
• Citations